Grant, D M <br/><br/>
Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model.  [electronic resource] 

 -  Pharmacotherapy   
 - 333-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0277-0008 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Acyclovir--analogs & derivatives<br/>Aged<br/>Antiviral Agents--economics<br/>Cost of Illness<br/>Cost-Benefit Analysis<br/>Double-Blind Method<br/>Drug Costs<br/>Herpes Zoster--drug therapy<br/>Humans<br/>Middle Aged<br/>Sensitivity and Specificity<br/>Valacyclovir<br/>Valine--analogs & derivatives